Diagnostic Photonics Featured in Chicago Tribune

Diagnostic Photonics, a Serra Capital I and II portfolio company, was featured in the Chicago Tribune on January 7. The Chicago startup has successfully raised $3.1M to fund a clinical trial for its high-resolution imaging probes for cancer surgeons.

The new funding will contribute to a nationwide, 400-person study with the goal of gaining FDA clearance. Serra Ventures was listed in the article as an investor in the round.

Source: http://www.chicagotribune.com/bluesky/orig...

Diagnostic Photonics Wins 2015 PROPEL Competition

Diagnostic Photonics, a Serra Capital I & II company, was named the winner of the 2015 PROPEL business plan competition on October 29. Diagnostic Photonics, based on technology from the University of Illinois Urbana Champaign, is a medtech company developing a handheld, high-resolution imaging system for cancer surgery.  The Foresee™ (4C) Imaging System will provide new, crucial information and insight on the extent of disease at the microscopic level.

Tim Hoerr, CEO of Serra Ventures, was quoted in the article, “In the last few years, the Diagnostic Photonics team has made tremendous progress in bringing a powerful cancer imaging technology to market. I’m pleased to see the recognition of this progress with the company’s first place win in the 2015 PROPEL Business Plan Competition. Serra Ventures is proud of its investment in and affiliation with this promising company.”

PROPEL is dedicated to increasing the number and success rate of early-stage life sciences companies in Illinois. The competition consisted of 20 companies from the Chicagoland area, and Diagnostic Photonics walked away with the $15,000 cash prize.

Source: http://www.businesswire.com/news/home/2015...

Diagnostic Photonics Featured by Research and Development Magazine

Diagnostic Photonics, a Serra Capital I and II portfolio company, was featured by R&D Magazine on September 16.  Diagnostic Photonics has developed a hand-held probe based on a technology called optical coherence tomography, which is used for surgical guidance and the real-time assessment of breast cancer tumor margin.

The tool which uses light to make sure surgeons removing cancerous tumors “got it all” was found to correlate well with traditional pathologists’ diagnoses in a clinical study, showing that the tool could soon enable reliable, real-time guidance for surgeons.

The interdisciplinary research team led by Stephen Boppart, a Univ. of Illinois professor, performed the study on 35 patients with breast cancers at the Carle Foundation Hospital in Urbana, Ill. The results appear in the journal Cancer Research.

Source: http://www.rdmag.com/news/2015/09/surgical...

Diagnostic Photonics and Oso Technologies Both Listed in Crain Chicago Magazine’s “Six Hot Startups”

Diagnostic Photonics and Oso Technologies, two Serra Capital portfolio companies, were both listed in Crain Chicago magazine’s “Six Hot Startups” on September 30.  Both companies represent two of the hottest growing sectors in Chicago.

Source: http://www.chicagobusiness.com/article/20130928/ISSUE02/130929799

Source: http://www.chicagobusiness.com/article/20130928/ISSUE02/130929793